Non-standardized allergenic · BLA
Short and Giant Ragweed Pollen Mix NDC 22840-0301
ambrosia artemisiifolia and ambrosia trifida · Ambrosia artemisiifolia pollen .025 g/mL; Ambrosia trifida pollen .025 g/mL · Solution · Intradermal, Percutaneous, Subcutaneous · Greer Laboratories, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 22840-0301-2 | 22840030102 | 10 mL in 1 VIAL, MULTI-DOSE (22840-0301-2)Marketed from Sep 15, 1981 | |
| 22840-0301-4 | 22840030104 | 50 mL in 1 VIAL, MULTI-DOSE (22840-0301-4)Marketed from Sep 15, 1981 | |
| 22840-0301-5 | 22840030105 | 5 mL in 1 BOTTLE, DROPPER (22840-0301-5)Marketed from Sep 15, 1981 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Short and Giant Ragweed Pollen Mix
- Generic name (nonproprietary)
- ambrosia artemisiifolia and ambrosia trifida
- Active ingredients
- Ambrosia artemisiifolia pollen — .025 g/mLAmbrosia trifida pollen — .025 g/mL
- Dosage form
- Solution
- Route
- Intradermal, Percutaneous, Subcutaneous
- Labeler
- Greer Laboratories, Inc.
- Product type
- Non-standardized allergenic
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 101844
- Marketing start
- Listing expires
- Other FDA classes
- Allergens (Chemical structure)Allergens (Chemical structure)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased IgG Production (Physiologic effect)Pollen (Chemical structure)Pollen (Chemical structure)
- Identifiers
- Product ID 22840-0301_36ac5d19-78f4-b1f4-e063-6294a90ae4cbSPL ID 36ac5d19-78f4-b1f4-e063-6294a90ae4cb
- Pharmacologic class
- Non-Standardized Pollen Allergenic Extract; Standardized Pollen Allergenic Extract
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N422840030102followed by a unit qualifier and the quantityPackage 22840-0301-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
Other NDCs under BLA 101844
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Short Ragweed Pollenambrosia artemisiifolia | Ambrosia artemisiifolia pollen .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | 22840-0300 |